IGF2 has been reported to improve neurocognitive functioning in patients with autism spectrum disorder,234 Huntington's Disease,138 amyotrophic lateral sclerosis (ALS),235 and Angelman Syndrome.167. Here, IGF2 is linked to amyotrophic lateral sclerosis.